J&J expands its PFA portfolio with the launch of Varipulse Professional in Europe
Johnson & Johnson (J&J) has launched Varipulse Professional in Europe after receiving CE Mark approval, strengthening its pulsed area ablation (PFA) portfolio.
The system introduces a brand new pulse sequence with a decrease temperature profile and an ablation that’s 5 instances sooner in comparison with the earlier sequence.
Uncover B2B advertising and marketing that delivers
Mix enterprise intelligence and editorial excellence to achieve engaged professionals throughout 36 main media platforms.
Extra info
It integrates with the Carto 3 system and makes use of superior mapping capabilities and tissue proximity indicators to make sure correct lesion supply.
J&J initiated the primary circumstances underneath the VARIPURE multicenter, potential, post-market extension examine, with the purpose of producing strong proof by means of this examine and different medical trials throughout the business rollout part.
J&J MedTech electrophysiology and neurovascular group president Michael Bodner mentioned: “The introduction of Varipulse Professional in Europe displays our dedication to advancing our PFA platforms by means of continued innovation, enhancing the procedural expertise whereas sustaining the consistency and precision physicians anticipate from the Varipulse platform.
“This launch demonstrates our dedication to repeatedly evolving PFA applied sciences, primarily based on real-world expertise and our scientific experience, supporting physicians in delivering high-quality care and improved affected person outcomes.”
The Varipulse Professional platform will probably be showcased on the European Coronary heart Rhythm Affiliation (EHRA) annual assembly, that includes reside case demonstrations, hands-on coaching periods {and professional} training.
Dr. Daniel Scherr, who served as a examine investigator and advisor for J&J, will current the interim 12-month outcomes of the continued VARIPURE trial on the EHRA PFA Summit. Varipulse Professional just isn’t at present permitted within the US.
Final month, J&J acquired approval from the U.S. Meals and Drug Administration (FDA) for its TECNIS PureSee prolonged depth of focus (EDOF) intraocular lens (IOL), designed to be used in cataract surgical procedure.
The TECNIS PureSee IOL is anticipated to be out there to US sufferers later this 12 months.
